Approved Study Database

Ref. No. Scientific Title Principal investigator
9406(S) A Prospective Randomized Phase III Study Comparing the Combination of Cisplatin, Doxorubicin, Interferon-Alpha-2B and 5-Fluorouracil to Doxorubicin Alone in the Treatment of Inoperable Hepatocellular Carcinoma Prof. YEO Winnie
2024.202 Atypical pre-attentive and attentive levels of information processing as a symptom- specific biomarker of children with autism spectrum disorder Dr. WONG Wing Ho
2024.165 Development and validation of a methylation signature for polycystic ovary syndrome Prof. MA Ronald Ching Wan
2024.162 Prevalence of Immune-Mediated Inflammatory Diseases (IMIDs) among the post-Coronavirus Disease 2019 (COVID-19) infection population Dr. ZHANG Lin
2024.160 Video Analysis for Automated Surgical Skill Assessment in Cataract Surgery Prof. CHENG Shing Shin
2024.159 Implementation of a novel diabetes prevention programme in Hong Kong Chinese workforce at high risk of type 2 diabetes Prof. LUK Andrea On Yan
2024.156 A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia Prof. YAN Bryan Ping Yen
甄秉言
2024.154 Empirical development of Standard Operation Procedures guiding nursing practice in specialties of Chinese medicine [本港中醫護理分科標準作業程序製訂研究] Prof. CHAIR Sek Ying
2024.151 fNIRS hyperscanning of peer interactions among preschoolers and young adolescents with developmental language disorders (DLD) Dr. ZHOU Xin
周欣
2024.150 Establishment of New Territories East Cluster Pancreatic Cancer Database Prof. CHAN Stephen
2024.149 Retrospective review of patients undergoing GI motility studies in the Prince of Wales Hospital Dr Ho Jacky C.L.
2024.148 The conflict status of fertility preservation decision-making and their impacts on decision results in childbearing-age female patients with cancer Prof. CHAN Carmen W.H.
2024.146 The efficacy and cost-effectiveness of a deep-learning system for supporting diabetic macular edema triage screening: a randomised controlled trial Dr. HO Mary
2024.145 Foundation Models-Empowered Ambient Intelligence Systems for Early Diagnosis, Personalized Intervention, and Complex Cross-Disease Interplay Analysis of Aging Related Degenerative Diseases Prof. XING Guoliang
邢國良
2024.144 Virtual Reality assisted Fitness for Fun (FF) intervention optimizes health and reduces cost of illness in Hong Kong older adults with mild neurocognitive disorders – a pragmatic trial Prof. LAM Linda Chiu Wa
2024.143 Prevalence and risk factors of intrafamilial Helicobacter pylori infection in Hong Kong: a prospective cohort study Dr. LAI Wan Ying
2024.142 Machine learning and prediction of major adverse cardiovascular events in patients prescribed second-generation antipsychotics - a territory-wide study Dr. CHAN Joey Wing Yan
2024.141 A prospective paired validating cohort study to evaluate an MRI-based optimized prostate cancer diagnostic pathway powered by artificial intelligence Dr. CHIU Peter Ka Fung
2024.138 Personalized Rehabilitation Pathways to Maximal Motor Functional Return through an AI Recovery Prediction System for Diverse Stroke Survivors Prof. CHEUNG Vincent Chi Kwan
張智鈞
2024.135 Correlation of the Neutrophil-to-Lymphocyte Ratio and Frontal QRS-T Angle to the Symptoms and Treatment Response of Local Patients with Non-Affective First Episode Psychosis Dr. WONG Yan Yee
黃恩兒
2024.134 Optimal Dosage of Atropine and Red Light Combination Therapy for Myopia Treatment (LAMP-4) Study Dr. YAM Jason Cheuk Sing
2024.131 Empathic Dysfunction: Development and Validation of a Heart Rate Variability Biofeedback (HRVB) Intervention of Emotion Sharing for People with Pertinent Psychopathology Symptoms Prof. CHIU Chui De
邱垂德
2024.130 Effect of Pulsed Electromagnetic Fields on Promoting Hamstring Muscle Strength after Anterior Cruciate Ligament Reconstruction with Hamstring Autograft: A Double-Blind, Placebo-Controlled, Randomised Clinical Trial Prof. LUI Pauline Po Yee
2024.129 Repeated Low-level Red Light for Myopia Progression Study: An International, Multicenter, Multiethnic, Randomized Controlled Trial, IPOSC Study Dr. YAM Jason Cheuk Sing
2024.128 Development of Building Respectful Online Space (BROS) Intervention for preventing cyberbully in Adolescents: A Qualitative Study Ms. SHI Yu
時豫
2024.127 Computer Use for Seniors on Mood Improvement and Logic Enhancement Dr. LEE Allen Ting Chun
2024.126 Effect of computerized cognitive training in dementia with depression: a pilot randomized controlled trial Dr. LEE Allen Ting Chun
Allen Ting Chun Lee
2024.125 Validation of the Cantonese (Traditional-Chinese) version of SCID-5-RV for Substance Use Disorder (C-SCID-5-SUD) among adult substance users in Hong Kong Dr. WONG Kwan
黃鈞
2024.122 A Nursing Student-Supported Mobile Health Intervention for South Asians in Hong Kong: A Feasibility Study Dr. CHAN Dorothy N.S.
2024.121 Unveiling the AI black-box: multi-modal vision-language models for explained discrimination of nasopharyngeal carcinoma and benign hyperplasia on MRI Dr. Wong Matthew Lun
黃麟
2024.120 Radical Radiotherapy vs Prostate Radiotherapy alone in low-volume metastatic de novo Hormone-sensitive prostate cancer Dr. YAN Cho Kiu Kelvin
2024.118 Epidemiology of Acute Sports Injuries in Hong Kong Elite Fencing Athletes Prof. YUNG Patrick Shu Hang
容樹恒
2024.115 Behavior, Aspirations and Treatment needs of people living with hepatitis B Professor Wong Lai Hung Grace
2024.114 Surveys to investigate injection site complications and pain related to androgen deprivation therapies in prostate cancer patients Prof. NG Chi Fai
吳志輝
2024.113 Multi-center Evaluation of Alpha-thalassaemia Early Eluting Peak, Immunochromatographic Strip Test and Haemoglobin H Inclusion Test for Alpha-thalassaemia Screening Dr. YUEN Carmen Michelle
2024.110 Determinants of early and late survival after surgery for cardiac tumours Prof. WONG Randolph Hung Leung
黃鴻亮
2024.109 Determinants of event-free survival and late reintervention after the Bentall procedure: A single-centre retrospective study Prof. WONG Randolph Hung Leung
黃鴻亮
2024.108 Genomic identification of ferroptosis-associated circRNAs in pancreatic ductal adenocarcinoma and functional characterization in tumor immune microenvironment Prof. CHEN Yang Chao
Yangchao Chen
2024.107 The effect of Short Message Service interventions on promoting exercise adherence for patients with knee conditions Prof. ONG Michael Tim-Yun
Michael Tim-Yun ONG
2024.106 Phase 1 randomised controlled clinical trial testing the safety and efficacy of CPP-anti-VEGF for the treatment of neovascular age-related macular degeneration Dr. BRELEN Mårten Erik
2024.105 Development of a Biobank for Studying the Pathogenesis and Treatment of Musculoskeletal Disorders Prof. LUI Po Yee Pauline
呂寶儀
2024.104 Coronal tibiofemoral subluxation after Oxford unicompartmental knee arthroplasties - a review of over 400 cases Dr. LAM Yan Ting
2024.102 Deciphering the association between HPV oncoproteins and Polo-like Kinase 1 Dr. BOON Siaw Shi
Siaw Shi Boon
2024.101 Functional Impact of Joint-line Obliquity and Left-right Symmetry in Patients with Oxford Unicompartmental Knee Arthroplasty Dr. LO Kelvin Chin Hei
2024.100 Evaluation of long-term effectiveness and cost-effectiveness of SGLT2-i and risk-based treatment strategies for primary prevention of cardiovascular-renal events in patients with type-2 diabetes utilizing a Chinese individual-patient simulation model Dr. LUI Juliana Nga Man
呂雅文
2024.099 A Randomised Controlled Trial of Ultrasound Guided Radiofrequency Ablation of Parotid Warthin's Tumor versus Parotidectomy Dr. YEUNG David
David Chun Man
2024.098 Establishment of a Hepatocellular Carcinoma Database Prof Chan Lam Stephen
2024.097 The impact of sign-phonological awareness training on language and literacy development in deaf and hearing bimodal bilingual children Prof. SZE Yim Binh Felix
2024.096 An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer Prof. YEO Winnie
2024.095 A Phase 1b/2, Open-Label, Dose Escalation and Expansion Study of ADG126 in Combination with Pembrolizumab (Anti-PD-1 Antibody) in Patients with Advanced/Metastatic Solid Tumors Prof. MA Brigette Buig Yue

Page 1 of 248.